MedPath

CELL-LOGIC PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

TGA:17

Drug Approvals

Gemmune M.M. (469545)

Product Name
Gemmune M.M.
Approval Date
Nov 20, 2024
TGA

GeneActiv Formulation D (462365)

Product Name
GeneActiv Formulation D
Approval Date
Sep 18, 2024
TGA

DefenCell (462234)

Product Name
DefenCell
Approval Date
Sep 13, 2024
TGA

GeneActiv Formulation D (443019)

Product Name
GeneActiv Formulation D
Approval Date
Mar 1, 2024
TGA

DefenCell (442012)

Product Name
DefenCell
Approval Date
Feb 22, 2024
TGA

Gemmune I.B. (307048)

Product Name
Gemmune I.B.
Approval Date
Jul 16, 2018
TGA

Gemmune M.M. (307053)

Product Name
Gemmune M.M.
Approval Date
Jul 16, 2018
TGA

GeneActiv Formulation E (294628)

Product Name
GeneActiv Formulation E
Approval Date
Oct 4, 2017
TGA

GeneActiv Formulation G (294630)

Product Name
GeneActiv Formulation G
Approval Date
Oct 4, 2017
TGA

GeneActiv Formulation C (294624)

Product Name
GeneActiv Formulation C
Approval Date
Oct 4, 2017
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.